CARLSBAD, Calif., June 30, 2021 /PRNewswire/ -- DCN Dx, an international provider of point-of-care diagnostics development, products, and educational programming, today announced it has completed its ...

REDDING, Calif., Oct. 24, 2024 /PRNewswire/ -- According to a new market research report, 'IVD Assay Development Market Size, Share, Forecast, & Trends Analysis by Offering (Assay Development, ...

GENCURIX signs as inaugural partner to develop multiplex oncology assays for tissue and liquid biopsies Partnership aims to broaden adoption of QIAcuityDx Four platform offering clinical diagnostic ...

DUBLIN--(BUSINESS WIRE)--The "IVD Assay Development Market Size, Share, Forecast, & Trends Analysis by Offering Technology, Application - Global Forecast to 2031" report has been added to ...

In the quest to cut costs and optimize operations, healthcare organizations are increasingly turning to business and engineering strategies such as Six Sigma, Lean, and the Toyota Production System.

Market Growth Driven by Rising Chronic Disease Prevalence, Increasing Geriatric Population, High Burden of Infectious Diseases, and Growing Focus on Point-of-Care IVD Assays REDDING, Calif., June 30, ...

AI transforms software development into a symphony by 2026, amplifying creativity, automating tasks, and redefining developer ...

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) and GENCURIX, Inc. (KOSDAQ: 229000) today announced a new partnership to develop oncology assays for use on the QIAcuityDx platform, a ...

Partnership aims to broaden adoption of QIAcuityDx Four platform offering clinical diagnostic laboratories a range of clinical oncology assays VENLO, Netherlands ...